Oral sucrosomial iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: a pilot study

PURPOSE: Erythropoiesis-stimulating agents (ESAs) are often used in treatment of patients with chemotherapy-induced anemia. Many studies have demonstrated an improved hemoglobin (Hb) response when ESA is combined with intravenous iron supplementation and a higher effectiveness of intravenous iron ov...

Full description

Saved in:
Bibliographic Details
Published in:Support Care Cancer
Main Authors: Mafodda, Antonino, Giuffrida, D., Prestifilippo, A., Azzarello, D., Giannicola, R., Mare, M., Maisano, R.
Format: Artigo
Language:Inglês
Published: Springer Berlin Heidelberg 2017
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5527057/
https://ncbi.nlm.nih.gov/pubmed/28391437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-017-3690-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items